Jon Våbenø

526 total citations
24 papers, 431 citations indexed

About

Jon Våbenø is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Jon Våbenø has authored 24 papers receiving a total of 431 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 16 papers in Molecular Biology and 8 papers in Immunology. Recurrent topics in Jon Våbenø's work include Chemokine receptors and signaling (15 papers), Chemical Synthesis and Analysis (7 papers) and Immunotherapy and Immune Responses (6 papers). Jon Våbenø is often cited by papers focused on Chemokine receptors and signaling (15 papers), Chemical Synthesis and Analysis (7 papers) and Immunotherapy and Immune Responses (6 papers). Jon Våbenø collaborates with scholars based in Norway, Denmark and United States. Jon Våbenø's co-authors include Mette M. Rosenkilde, Kristina Luthman, Tore Lejon, Stefanie Thiele, Gregory V. Nikiforovich, Garland R. Marshall, Bente Steffansen, Carsten Uhd Nielsen, Anne Steen and Bengt Erik Haug and has published in prestigious journals such as FEBS Letters, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Jon Våbenø

24 papers receiving 420 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jon Våbenø Norway 13 235 228 104 74 57 24 431
Jaimeen D. Majmudar United States 15 567 2.4× 142 0.6× 44 0.4× 163 2.2× 32 0.6× 24 813
Jason Crawford Canada 12 188 0.8× 138 0.6× 89 0.9× 218 2.9× 30 0.5× 16 512
Jeremy A. Smith United States 13 369 1.6× 114 0.5× 46 0.4× 124 1.7× 16 0.3× 16 639
Gary A. Cain United States 11 261 1.1× 50 0.2× 45 0.4× 192 2.6× 31 0.5× 19 555
Jessica Iegre United Kingdom 14 533 2.3× 167 0.7× 31 0.3× 180 2.4× 99 1.7× 19 707
Regina Tugyi Hungary 5 237 1.0× 94 0.4× 25 0.2× 51 0.7× 53 0.9× 6 344
Sharon Boggs United States 11 232 1.0× 146 0.6× 38 0.4× 202 2.7× 15 0.3× 12 513
Yoshihiko Odagaki Japan 14 226 1.0× 93 0.4× 52 0.5× 332 4.5× 17 0.3× 28 563
Davide Carta Italy 14 200 0.9× 93 0.4× 23 0.2× 195 2.6× 138 2.4× 35 535
Hanna Hailu United Kingdom 7 436 1.9× 99 0.4× 58 0.6× 211 2.9× 118 2.1× 10 611

Countries citing papers authored by Jon Våbenø

Since Specialization
Citations

This map shows the geographic impact of Jon Våbenø's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jon Våbenø with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jon Våbenø more than expected).

Fields of papers citing papers by Jon Våbenø

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jon Våbenø. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jon Våbenø. The network helps show where Jon Våbenø may publish in the future.

Co-authorship network of co-authors of Jon Våbenø

This figure shows the co-authorship network connecting the top 25 collaborators of Jon Våbenø. A scholar is included among the top collaborators of Jon Våbenø based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jon Våbenø. Jon Våbenø is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Larsen, Olav, et al.. (2023). Chemokine N‐terminal‐derived peptides differentially regulate signaling by the receptors CCR1 and CCR5. FEBS Letters. 597(24). 3049–3060. 1 indexed citations
2.
Våbenø, Jon, et al.. (2023). Identification of a Salt Bridge That Is Functionally Important for Chemokine Receptor CXCR1 but not CXCR2. ACS Pharmacology & Translational Science. 6(8). 1120–1128. 1 indexed citations
3.
Berg, Christian, Jon Våbenø, Francis C. Peterson, et al.. (2022). The non-ELR CXC chemokine encoded by human cytomegalovirus UL146 genotype 5 contains a C-terminal β-hairpin and induces neutrophil migration as a selective CXCR2 agonist. PLoS Pathogens. 18(3). e1010355–e1010355. 4 indexed citations
4.
Larsen, Olav, Wijnand J. C. van der Velden, Martin Gustavsson, et al.. (2022). Identification of a conserved chemokine receptor motif that enables ligand discrimination. Science Signaling. 15(724). eabg7042–eabg7042. 3 indexed citations
5.
Filippo, Katia De, Christian Berg, Tau Benned‐Jensen, et al.. (2021). Biased action of the CXCR4-targeting drug plerixafor is essential for its superior hematopoietic stem cell mobilization. Communications Biology. 4(1). 569–569. 35 indexed citations
6.
Lückmann, Michael, et al.. (2021). Discovery of GPR183 Agonists Based on an Antagonist Scaffold. ChemMedChem. 16(17). 2623–2627. 8 indexed citations
7.
Cagno, Massimiliano Pio di, et al.. (2018). Experimental Determination of Drug Diffusion Coefficients in Unstirred Aqueous Environments by Temporally Resolved Concentration Measurements. Molecular Pharmaceutics. 15(4). 1488–1494. 55 indexed citations
8.
Fossen, Torgils, et al.. (2017). Synthesis of a novel tripeptidomimetic scaffold and biological evaluation for CXC chemokine receptor 4 (CXCR4) antagonism. Tetrahedron. 73(27-28). 3866–3877. 2 indexed citations
9.
Hussain, Mohammad Musarraf, et al.. (2016). Influence of chain length on the activity of tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4). Bioorganic & Medicinal Chemistry. 25(2). 646–657. 4 indexed citations
10.
Haug, Bengt Erik, et al.. (2015). Probing the Molecular Interactions between CXC Chemokine Receptor 4 (CXCR4) and an Arginine-Based Tripeptidomimetic Antagonist (KRH-1636). Journal of Medicinal Chemistry. 58(20). 8141–8153. 17 indexed citations
11.
Thiele, Stefanie, et al.. (2014). Design, synthesis, and biological evaluation of scaffold-based tripeptidomimetic antagonists for CXC chemokine receptor 4 (CXCR4). Bioorganic & Medicinal Chemistry. 22(17). 4759–4769. 14 indexed citations
12.
Thiele, Stefanie, et al.. (2013). Structure–activity relationship studies of the aromatic positions in cyclopentapeptide CXCR4 antagonists. Organic & Biomolecular Chemistry. 11(47). 8202–8202. 12 indexed citations
13.
Thiele, Stefanie, et al.. (2012). Rational Design of Conformationally Constrained Cyclopentapeptide Antagonists for C-X-C Chemokine Receptor 4 (CXCR4). Journal of Medicinal Chemistry. 55(22). 10287–10291. 22 indexed citations
14.
Våbenø, Jon, Gregory V. Nikiforovich, & Garland R. Marshall. (2006). A minimalistic 3D pharmacophore model for cyclopentapeptide CXCR4 antagonists. Biopolymers. 84(5). 459–471. 16 indexed citations
15.
Våbenø, Jon, Gregory V. Nikiforovich, & Garland R. Marshall. (2006). Insight into the Binding Mode for Cyclopentapeptide Antagonists of the CXCR4 Receptor. Chemical Biology & Drug Design. 67(5). 346–354. 28 indexed citations
16.
Jørgensen, Flemming Steen, et al.. (2006). Development of a QSAR Model for Binding of Tripeptides and Tripeptidomimetics to the Human Intestinal Di-/Tripeptide Transporter hPEPT1. Pharmaceutical Research. 23(3). 483–492. 13 indexed citations
17.
Våbenø, Jon, Carsten Uhd Nielsen, Bente Steffansen, et al.. (2005). Conformational restrictions in ligand binding to the human intestinal di-/tripeptide transporter: implications for design of hPEPT1 targeted prodrugs. Bioorganic & Medicinal Chemistry. 13(6). 1977–1988. 6 indexed citations
18.
Nielsen, Carsten Uhd, et al.. (2005). Recent advances in therapeutic applications of human peptide transporters. Expert Opinion on Therapeutic Patents. 15(2). 153–166. 11 indexed citations
19.
Gullbo, Joachim, Jon Våbenø, Hans Ehrsson, et al.. (2003). Structure–Activity Relationship for Alkylating Dipeptide Nitrogen Mustard Derivatives. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 14(3). 113–132. 30 indexed citations
20.
Våbenø, Jon, et al.. (2002). Diastereoselective Reduction of a Chiral N-Boc-Protected δ-Amino-α,β-unsaturated γ-Keto Ester Phe-Gly Dipeptidomimetic. The Journal of Organic Chemistry. 67(26). 9186–9191. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jaimeen D. Majmudar Breakdown of academic impact, for papers by Jason Crawford Breakdown of academic impact, for papers by Jeremy A. Smith Breakdown of academic impact, for papers by Gary A. Cain Breakdown of academic impact, for papers by Jessica Iegre Breakdown of academic impact, for papers by Regina Tugyi Breakdown of academic impact, for papers by Sharon Boggs Breakdown of academic impact, for papers by Yoshihiko Odagaki Breakdown of academic impact, for papers by Davide Carta Breakdown of academic impact, for papers by Hanna Hailu
Rankless by CCL
2026